Parallel genome-wide screens identify synthetic viable interactions between the BLM helicase complex and Fanconi

Martin Moder1, Georgia Velimezi1, Michel Owusu1

  • 1CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Lazarettgasse 14, AKH BT 25.3, 1090, Vienna, Austria.

Nature Communications
|November 2, 2017
PubMed

Insights

Loss of the BLM helicase complex suppresses Fanconi anemia (FA) phenotypes in FANCC-deficient cells. This genetic interaction extends beyond the FA core complex, revealing new therapeutic targets for DNA repair defects.

Area of Science:

  • Genetics
  • Molecular Biology
  • Genomic Stability

Background:

  • DNA damage repair is crucial for preventing diseases like Fanconi anemia (FA).
  • The FA pathway involves multiple protein complexes, including the FA core complex and the FA I-D2 complex, essential for genome integrity.
  • Understanding genetic interactions in FA can identify new therapeutic strategies.

Purpose of the Study:

  • To identify genetic suppressors of Fanconi anemia (FA) using loss-of-function haploid cells.
  • To investigate synthetic viable interactions for FA complementation group C (FANCC) defects.
  • To explore genome-wide screening approaches for uncovering genetic interactions in DNA repair pathways.

Main Methods:

  • Generated loss-of-function human haploid cells for FANCC.
  • Utilized genome-wide CRISPR libraries and insertional mutagenesis for screening.
  • Confirmed genetic interactions in cells deficient for FANCI and FANCD2.

Main Results:

  • Identified the BLM helicase complex as a genetic suppressor of FANCC loss-of-function.
  • Demonstrated that the BLM helicase complex suppresses phenotypes in FANCI and FANCD2 deficient cells.
  • Showed that this interaction is not restricted to the FA core complex.

Conclusions:

  • Loss of the BLM helicase complex can functionally suppress defects in the Fanconi anemia pathway.
  • Genome-wide screening is effective in identifying genetic interactions for DNA repair deficiencies.
  • These findings highlight potential therapeutic targets for FA and related disorders.